Karcinom Merklovih celic

Show document
A+ | A- | | SLO | ENG

Title:	Karcinom Merklovih celic
Authors:	ID Eržen, Darja (Author)
Files:	PDF - Presentation file, download (717,49 KB) MD5: 5F1146C557AC11DD3F86B52E7C9AF174 PID: 20.500.12556/dirros/0c045f31-2398-4aae-ad91-cc29e2515901
Language:	Slovenian
Typology:	1.01 - Original Scientific Article
Organization:	OI - Institute of Oncology
Abstract:	Karcinom Merklovih celic (MCC) je redek, agresiven in pogosto smrten nevroendokrini kožni karcinom. Zanimanje zanj se v zadnjem času veča zaradi naraščanja incidence in možne virusne povezave. V prispevku so opisani klinična slika, zamejitveni sistem in zdravljenje ter izkušnje Onkološkega inštituta Ljubljana (OIL). Prikazan je pregled serije 40 bolnikov, zdravljenih na OIL od 1994 do 2011.
Publication status:	Published
Publication version:	Version of Record
Year of publishing:	2012
Number of pages:	str. 14-17, 59
Numbering:	Letn. 16, št. 1
PID:	20.500.12556/DiRROS-8899
UDC:	616.15-006.6-07-08
ISSN on article:	1408-1741
URN:	URN:NBN:SI:doc-WLIW79VI
COBISS.SI-ID:	1319291
Copyright:	by Authors
Publication date in DiRROS:	31.08.2018
Views:	2648
Downloads:	681
Metadata:
:	Copy citation

Share:

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Title:	Onkologija. strokovni časopis za zdravnike
Shortened title:	Onkologija
Publisher:	Onkološki inštitut
ISSN:	1408-1741
COBISS.SI-ID:	65324032

License:	CC BY 4.0, Creative Commons Attribution 4.0 International

Link:	http://creativecommons.org/licenses/by/4.0/
Description:	This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:	31.08.2018

Language:	English
Title:	Merkel cell carcinoma
Abstract:	The Merkel Cell Carcinoma (MCC) is a rare, aggressive and often deadly neuroendocrine skin carcinoma. Recently, there has been a growing interest in this type of cancer due to its increasing incidence and possible viral connection. The article presents the clinical picture, staging system, treatment and experience of the Institute of Oncology Ljubljana (IOL). Also included is a review of 40 patients treated at the IOL from 1994 to 2011.